| Genomic Classification and Prognosis in Acute Myeloid Leukemia E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ... New England Journal of Medicine 374 (23), 2209-2221, 2016 | 4113 | 2016 |
| Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020 | 747 | 2020 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 541 | 2020 |
| Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature genetics 52 (3), 306-319, 2020 | 348 | 2020 |
| Somatic mutations and clonal dynamics in healthy and cirrhotic human liver SF Brunner, ND Roberts, LA Wylie, L Moore, SJ Aitken, SE Davies, ... Nature 574 (7779), 538-542, 2019 | 318 | 2019 |
| Mutational signatures of ionizing radiation in second malignancies S Behjati, G Gundem, DC Wedge, ND Roberts, PS Tarpey, SL Cooke, ... Nature Communications 7, 2016 | 271 | 2016 |
| Prognosis for patients with CML and> 10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline S Branford, DT Yeung, WT Parker, ND Roberts, L Purins, JA Braley, ... Blood, 2014 | 233 | 2014 |
| Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors ND Anderson, R de Borja, MD Young, F Fuligni, A Rosic, ND Roberts, ... Science 361 (6405), 2018 | 156 | 2018 |
| Germline MC1R status influences somatic mutation burden in melanoma CD Robles-Espinoza, ND Roberts, S Chen, FP Leacy, LB Alexandrov, ... Nature communications 7 (1), 1-7, 2016 | 142 | 2016 |
| A comparative analysis of algorithms for somatic SNV detection in cancer ND Roberts, RD Kortschak, WT Parker, AW Schreiber, S Branford, ... Bioinformatics 29 (18), 2223-2230, 2013 | 125 | 2013 |
| BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma K Herbert, R Binet, JP Lambert, P Louphrasitthiphol, H Kalkavan, ... Genes & development 33 (5-6), 310-332, 2019 | 44 | 2019 |
| Selective and mechanistic sources of recurrent rearrangements across the cancer genome JA Wala, O Shapira, Y Li, D Craft, SE Schumacher, M Imielinski, JE Haber, ... BioRxiv, 187609, 2017 | 29 | 2017 |
| Any BCR-ABL Reduction Below 10% At 6 Months Of Therapy Significantly Improves Outcome For CML Patients With a Poor Response At 3 Months N Roberts, DT Yeung, H Altamura, WT Parker, TP Hughes Blood 122 (21), 254-254, 2013 | 22 | 2013 |
| Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... BioRxiv, 179705, 2018 | 18 | 2018 |
| Patterns of structural variation in human cancer Y Li, ND Roberts, J Weischenfeldt, JA Wala, O Shapira, SE Schumacher, ... BioRxiv, 181339, 2017 | 18 | 2017 |
| Patterns of somatic genome rearrangement in human cancer ND Roberts University of Cambridge, 2018 | 16 | 2018 |
| Additional BCR-ABL1 Mutations Identified By Sensitive Mass Spectrometry In Chronic Phase CML Patients With T315I Treated With Ponatinib Are Associated With Relatively Inferior … WT Parker, AL Yeoman, H Altamura, N Roberts, DT Yeung, BA Jamison, ... Blood 122 (21), 651-651, 2013 | 1 | 2013 |
| Exploring the complex etiology of oncogenic fusions in childhood cancer ND Anderson, R de Borja, MD Young, F Fuligni, A Rosic, ND Roberts, ... Cancer Research 79 (13 Supplement), 2506-2506, 2019 | | 2019 |
| PROGNOSIS FOR CML PATIENTS WITH> 10% BCR-ABL AFTER 3 MONTHS OF IMATINIB DEPENDS ON THE INITIAL RATE OF BCR-ABL DECLINE S Branford, D Yeung, WT Parker, L Purins, J Braley, JF Seymour, ... HAEMATOLOGICA 99, 74-74, 2014 | | 2014 |
